<h1>360 ONE and Claypond Capital Partners to Acquire Stakes in API Holdings, Parent Company of Pharmeasy</h1> The Competition Commission of India has approved 360 ONE and Claypond Capital Partners' joint acquisition of stakes in API Holdings, a digital healthcare platform operating through subsidiaries like Pharmeasy, Thyrocare, and Retailio. The transaction involves 360 ONE acquiring compulsorily convertible preference shares from existing shareholder MEMG Family Office LLP. In a separate approval, CCI cleared the acquisition of additional voting rights by certain shareholders of Billionbrains Garage Ventures (Groww) and the issuance of bonus compulsorily convertible preference shares to all existing equity shareholders, including venture capital firms Peak XV Partners, Ribbit, and others.